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Annual volume of pancreatic resections has been shown to affect mortality rates, prompting recommendations to regionalize these
procedures to high-volume hospitals. Implementation has been difficult, given the paucity of high-volume centers and the logistical
hardships facing patients. Some studies have shown that low-volume hospitals achieve good outcomes as well, suggesting that other
factors are involved. We sought to determine whether variations in annual volume affected patient outcomes in 511 patients who
underwent pancreatic resections at the University of California, San Francisco between 1990 and 2005. We compared postoperative
mortality and complication rates between low, medium, or high volume years, designated by the number of resections performed,
adjusting for patient characteristics. Postoperative mortality rates did not differ between high volume years and medium/low
volume years. As annual hospital volume of pancreatic resections may not predict outcome, identification of actual predictive
factors may allow low-volume centers to achieve excellent outcomes.
Copyright © 2008 Rita A. Mukhtar et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The desire to improve surgical outcomes has resulted in
significant interest in volume-outcome relationships. As
insurance companies continue developing policies that may
use hospital volume to influence patient choice of treatment
center [1], the importance of the issue increases. For
pancreatic resections specifically, many studies have found
that higher annual volume predicts lower mortality rates
[1–10]. Such findings have led some to advocate region-
alization of pancreatic resections [3, 7–11]. Despite this
call, however, there have been practical limitations to such
centralization [12]. In addition, the validity of studies that
typically rely on administrative databases for information
has been questioned [13]. A recent study from our institution
suggested that the observed benefits at high-volume hospitals
may be “exported” to low-volume hospitals, suggesting that
factors other than volume alone may contribute to outcomes
[14].
Few studies have focused on the effects of annual
fluctuations in hospital volume on outcome for pancreatic
resections. Additionally, most studies group different types
of pancreatic resections together instead of distinguishing
between pancreatic head resections and non-head resections
[10]. Furthermore, many studies have examined the rela-
tionship between annual volume and mortality but have not
addressed whether volume affects postoperative complica-
tion rates. We sought to determine whether the reported
volume-outcome relationships would be observed over time
at a single institution for both mortality and postoperative
complications, and whether those relationships would hold
true for specific types of pancreatic resections. We also
looked at trends in pancreatic resections performed at our
institution over 16 years to determine which factors were
associated with postoperative complications.
2. MATERIALS AND METHODS
2.1. Patient selection
The paper and electronic charts of 511 patients who
underwent pancreatic resection at UCSF’s Moffitt Hospital
between January 1990 and October 2005 were retrospectively
reviewed. Patients were identified through a computerized
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search for procedural codes from the International Classifi-
cation of Diseases, 9th Revision, Clinical Modification (ICD-
9-CM) corresponding to the following diagnoses: partial
pancreatectomy, proximal pancreatectomy, distal pancre-
atectomy, radical subtotal pancreatectomy, other partial
pancreatectomy, and pancreaticoduodenectomy (PD). We
excluded patients who were identified by the comput-
erized search but did not in fact undergo actual pan-
creatic resection (e.g., those who had pancreaticojejunos-
tomy, pancreatic debridement, or pancreas transplant). We
also excluded patients who were younger than 16 years
of age at the time of resection. Race/ethnicity was col-
lected as recorded on the patients’ records. The Univer-
sity of California, San Francisco Committee on Human
Research approved this study prior to the review of patient
records.
2.2. Demographic and clinical characteristics
The following data were recorded for each patient: age,
gender, ethnicity, ASA score, indication for operation, opera-
tion type, pathologic diagnosis, postoperative complications,
length of stay, and in-hospital mortality.
Operation types included PD, pylorus-preserving PD,
distal pancreatectomy, spleen-sparing distal pancreatectomy,
subtotal pancreatectomy, total pancreatectomy, and total
pancreatectomy with islet autotransplantation.
Pathologic diagnoses were grouped into pancreatic ade-
nocarcinoma, periampullary tumor, cystic tumor, neuroen-
docrine tumor, chronic pancreatitis, gastrointestinal stromal
tumor, metastatic tumors, or “other.” Periampullary tumors
included neoplasms of the common bile duct, ampulla of
Vater, and duodenum. Cystic tumors included intraductal
papillary mucinous tumors, mucinous cystadenoma, muci-
nous cystadenocarcinoma, microcystic adenoma, serous
cystadenoma, and solid and papillary neoplasms. All other
findings were categorized as “other.”
2.3. Outcomes
Postoperative complications were assessed by clinical diagno-
sis noted in the medical record, and included wound infec-
tion, pancreatic fistula/leak, gastroparesis, bile leak, reop-
eration, bleeding, pneumonia, and urinary tract infection
(UTI). Less frequent complications were grouped together as
“other,” a category that included pleural effusion, pulmonary
edema, pulmonary embolus, arrhythmia, myocardial infarc-
tion, wound dehiscence, Clostridium difficile colitis, acute
renal failure, incisional hernia, and bacteremia.
To evaluate the effect of annual volume on outcomes,
each study year was listed by number of resections per-
formed. To maximize differences between the low volume
and high volume groups, the years were then divided
by volume into three roughly equally sized groups: high,
medium, and low. To further determine whether the volume
of a specific type of pancreatic resection could predict
outcomes, years were categorized in two ways: based on
volume of pancreatic head resections performed, and by the
volume of non-head resections performed.
2.4. Statistical analysis
We used multiple logistic regression to examine all rela-
tionships between annual volume and outcome, adjusting
for patient gender, presence of underlying malignancy on
pathological diagnosis, race (white or nonwhite), and age.
Additionally, t-tests and chi-square tests were used where
appropriate, with statistical significance set at P < .05. Data
are presented as mean ± standard deviation (SD) unless
otherwise indicated. Data were analyzed using statistical
analysis software (SAS) (Cary, NC, USA) and STATA (Col-
lege Station, Tex, USA).
3. RESULTS
3.1. Patient characteristics
Of the 511 patients who underwent pancreatic resections
during the 16-year study period, 52% were females. The
average age was 58.6 ± 14.7 years. Most patients (61%) are
self-identified as White.
3.2. Procedures
The majority (60%) of resections performed were pancreatic
head resections (PD); non-head resections (40%) comprised
distal, subtotal, or total pancreatectomies. Among the pan-
creatic head resections, more than (60%) were pylorus-
preserving PD as opposed to classical PD.
Among the non-head resections, 85% were distal pancre-
atectomies.
3.3. Pathologic diagnoses
The most common pathologic diagnosis was adenocarci-
noma of the pancreas (25%), followed by periampullary
tumors and cystic tumors. Three of the 33 patients with
a preoperative diagnosis of chronic pancreatitis had final
pathologic results that indicated malignancy. Conversely, 15
(24%) of the 62 patients with a final diagnosis of chronic
pancreatitis were erroneously believed to have a malignancy
preoperatively.
3.4. Comparison of complication rates for head and
non-head pancreatic resections
Rates of wound infections, intraabdominal abscesses, pan-
creatic fistulas, gastroparesis, reoperations, and “other”
complications were significantly higher in patients who
underwent pancreatic head resections than in those who
underwent non-head resections. Not surprisingly, patients
who underwent pancreatic head resections also had signif-
icantly longer hospital stays (mean of 14.9 days versus 10.7
days). Length of stay ranged from 2–373 days with a median
of 11 days for pancreatic head resections, and 1–56 days with
a median of 8 days for non-head resections. Additionally,
slightly more surgical complications occurred in patients
with an underlying malignancy (34.4%) than in patients with
benign disease (25.3%).
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Table 1: High, medium, and low volume groups based on either
pancreatic head resection volume, or non-head resection volume.
Head
resection
volume
groups∗
Number of
head
resections
performed
Non-head
resection
volume
groups
Number of
non-head
resections
performed
High
volume
years
High
volume
years
2002 42 2000 28
2000 38 2002 22
1998 33 1999 20
2001 31 2001 19
1999 28 2004 16
Medium
volume
years
Medium
volume
years
1997 23 2005 14
1995 19 1991 14
2003 17 1994 10
1993 14 1995 10
1994 13 2003 11
Low
volume
years
Low
volume
years
1996 12 1996 9
2004 11 1992 8
2005 8 1990 6
1992 7 1993 6
1991 5 1997 6
1990 5 1998 6
∗
Each study year was listed by number of resections performed. The years
were then divided by volume into three roughly equally sized groups: high,
medium, and low.
3.5. Effect of annual volume on resection outcome
An average of 32 ± 17 pancreatic resections were done
annually during the years included in this study. A higher
than average number of resections (n = 262) was performed
between 1998–2002, but the numbers declined beginning
in 2003, possibly related to the departure of one particular
surgeon. With some exceptions, trends in the volume of
non-head pancreatic resections generally followed those of
head resections (Figure 1). However, because the volume
of head resections did not necessarily increase or decrease
concordantly with the volume of non-head resections, we
first used the rates of pancreatic head resections to define
high, medium, and low volume years, and then used the rates
of non-head resections to do so (Table 1).
We found that among patients who underwent any
pancreatic resection in low volume years as defined by
number of head resections performed, there were no in-
hospital deaths. When medium and low volume years
were combined for purposes of statistical analysis, there
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Figure 1: Annual pancreatic resection volume broken down by
head resections and non-head resections. Trends in the volume of
non-head pancreatic resections generally followed those of head
resections, with some exceptions.
was no difference in death rates for either pancreatic
head resections (odds ratio = 1.62, P = .64) or non-head
resections (odds ratio = 1.09, P = .9) between high volume
years and low/medium volume years. In addition, there
were no significant differences in postoperative complication
rates among patients undergoing non-head resection in high
versus low volume years. The incidence of gastroparesis
(odds ratio = 0.57, P = .7) and bleeding (odds ratio = 0.344,
P = .398) was lower in high volume years, but not sig-
nificantly so, and the incidence of UTIs was higher, but
again, not significantly so (odds ratio = 4.26, pq = 0.199)
(Table 2). The only difference was that there were signifi-
cantly fewer bile leaks in patients who underwent pancreatic
head resection in a high-volume head resection year (odds
ratio = 0.09, P < .05) (Table 2).
When the rates of pancreatic non-head resections were
used to define high, medium, and low volume years, there
was no significant difference in death rates for either pan-
creatic head resections (odds ratio = 1.13, P = .923) or non-
head resections (odds ratio = 0.652, P = .611) performed in
high volume years versus low volume years. The same was
true for complication rates (odds ratios = 0.734 for non-
head resections, and 0.798 for head resections). Although for
patients undergoing non-head resections, the incidence of
gastroparesis in high volume years was lower, the difference
was not significant (odds ratio = 0.338, P = .453), nor was
the higher incidence of intraabdominal abscesses (odds
ratio = 1.92, P = .554). Similarly, patients undergoing head
resections had fewer wound infections, bile leaks, cases of
pneumonia, and less bleeding in high volume years, but
again, the differences were not significant (Table 3).
4. DISCUSSION
Our findings show that at a single institution variation in
annual pancreatic resection volume does not affect mortality.
In fact, there were no in-hospital deaths following pancreatic
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Table 2: Postoperative complication and mortality rates by low, medium, and high volume years as defined by the number of pancreatic
head resections performed.∗
Low volume years∗ Medium volume years High volume years
Non-head
resections
(n = 66)
Head
resections
(n = 49)
Non-head
resections
(n = 43)
Head
resections
(n = 86)
Non-head
resections
(n = 96)
Head
resections
(n = 172)
Total
(n = 511)
Death 0 (0%) 0 (0%) 2 (4.7%) 3 (3.5%) 2 (2.1%) 4 (2.3%) 11 (2.2%)
Wound infection 1 (1.5%) 4 (8.2%) 2 (4.7%) 16 (18.6%) 6 (6.3%) 17 (9.9%) 46 (9%)
Pancreatic fistula 3 (4.5%) 4 (8.2%) 0 (0%) 14 (16.3%) 5 (5.2%) 14 (8.2%) 40 (7.8%)
Gastroparesis 1 (1.5%) 5 (10.2%) 1 (2.3%) 10 (11.6%) 1 (1%) 16 (9.4%) 34 (6.7%)
Intraabdominal abscess 3 (4.5%) 6 (12.2%) 3 (7%) 16 (18.6%) 5 (5.2%) 20 (11.7%) 53 (10.4%)
Bile leak 0 (0%) 3 (6.1%) 0 (0%) 1 (1.2%) 0 (0%) 1 (0.6%) 5 (1%)
Pneumonia 0 (0%) 2 (4.1%) 2 (4.7%) 6 (7%) 2 (2.1%) 7 (4.1%) 19 (3.7%)
Urinary tract infection 1 (1.5%) 1 (2%) 2 (4.7%) 2 (2.3%) 5 (5.2%) 14 (8.2%) 25 (4.9%)
Postoperative bleeding 2 (3%) 1 (2%) 0 (0%) 4 (4.7%) 1 (1%) 4 (2.3%) 12 (2.3%)
Reoperation 3 (4.5%) 3 (6.1%) 4 (9.3%) 7 (8.1%) 1 (1%) 13 (7.6%) 31 (6.1%)
Other 9 (13.6%) 18 (36.7%) 8 (18.6) 30 (34.9%) 14 (14.6%) 65 (38%) 144 (28.2%)
∗
Each study year was listed by number of resections performed. The years were then divided by volume into three roughly equally sized groups: high, medium,
and low.
Table 3: Postoperative complication and mortality rates by low, medium, and low volume years as defined by the number of non-head
resections performed.∗
Low volume years Medium volume years High volume years
Non-head
resections
(n = 42)
Head
resections
(n = 93)
Non-head
resections
(n = 57)
Head
resections
(n = 64)
Non-head
resections
(n = 106)
Head
resections
(n = 149)
Total
(n = 511)
Death 1 (2.1%) 3 (3.2%) 1 (1.8%) 1 (1.6%) 2 (1.9%) 3 (2%) 11 (2.2%)
Wound infection 2 (4.8%) 14 (15.1%) 1 (1.8%) 10 (15.6%) 6 (5.7%) 13 (8.7%) 46 (9%)
Pancreatic fistula 1 (2.4%) 9 (9.7%) 1 (1.8%) 9 (14.1%) 6 (5.7%) 14 (9.4%) 40 (7.8%)
Gastroparesis 1 (2.4%) 6 (6.5%) 1 (1.8%) 9 (14.1%) 1 (0.9%) 16 (10.7%) 34 (6.7%)
Intraabdominal abscess 1 (2.4%) 14 (15.1%) 4 (7%) 10 (15.6%) 6 (5.7%) 18 (12.1%) 53 (10.4%)
Bile leak 0 (0%) 2 (2.2%) 0 (0%) 1 (1.6%) 0 (0%) 2 (1.3%) 5 (1%)
Pneumonia 1 (2.4%) 7 (7.5%) 1 (1.8%) 3 (4.7%) 2 (1.9%) 5 (3.4%) 19 (3.7%)
Urinary tract infection 0 (0%) 6 (6.5%) 3 (5.3%) 2 (3.1%) 5 (4.7%) 9 (6%) 25 (4.9%)
Postoperative bleeding 0 (0%) 6 (96.5%) 1 (1.8%) 0 (0%) 2 (1.9%) 3 (2%) 12 (2.3%)
Reoperation 3 (7.1%) 7 (97.5%) 3 (5.3%) 6 (9.4%) 2 (1.9%) 10 (6.7%) 31 (6.1%)
Other 7 (16.7%) 38 (40.9%) 9 (15.8%) 22 (34.4%) 15 (14.2%) 53 (35.6%) 144 (28.2%)
∗
Each study year was listed by number of resections performed. The years were then divided by volume into three roughly equally sized groups: high, medium,
and low.
head resection during the six low volume years included in
the study. Although our hospital’s volumes may be consid-
ered high by some criteria, during four of the six low volume
years, we did not meet the Leapfrog consortium’s cutoff
for being an index center (11 pancreatic head resections
per year) [15], suggesting that our low volume group is
truly reflective of low volumes based on nationally accepted
standards. The results presented here are discordant with
the previously demonstrated inverse relationship between
pancreatic resection volume and mortality [2–10]. In fact,
the findings seem to suggest that “once a high-volume
hospital, always a high-volume hospital,” even if fluctuations
in volume actually give that hospital low-volume status
for a given period of time. If this is the case, there must
be some factor that affords the hospital the ability to
maintain excellent mortality rates independent of volume.
The existence of such a factor supports the notion that the
systems in place at a particular institution [4, 16] may be
the effectors of outcome, and suggests that a higher volume
may be a proxy for the presence of these systems. This may
explain why some low-volume hospitals have been able to
achieve low mortality rates [3], and why it may be possible to
“export” good outcomes to low-volume hospitals [14]. Many
studies support the idea that volume is only one part of a
complex system of factors that affect outcomes, with findings
such as race [17], the proportion of minorities treated at
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a given hospital, surgeon volume [18], and even surgeon
age [19] playing roles in surgical mortality. An advantage
of the grouping method used in our study is that each
group contains a diverse range of years (e.g., the low volume
group contains years 1990 and 2005), possibly reducing the
contribution from any one surgeon.
Although some trends toward fewer complications in
high volume years were observed, only the incidence of bile
leaks following pancreatic head resection was significantly
lower in the high volume years. We have not seen this specific
finding in published reports, but a recent study did show
decreased complication rates following pancreatic resection
as volume increased in an already high-volume hospital
[20]. Some have suggested that differences in the quality
of managing postoperative complications may account for
differences in-hospital outcomes [21]; however, in the prior
study, and the one reported here, mortality rates remained
unchanged despite changing trends in complication rates.
Additionally, during the period of time included in the study,
there was no system-wide initiation of a preoperative or
postoperative pathway for patients undergoing pancreatic
resection.
It is possible that although we had high and low volume
years, we failed to find a difference in mortality rates because
we divided pancreatic resections into head and non-head
resections when creating our volume groups. Had we instead
used all pancreatic resections to define the groups, our low
volume years may have exceeded the volume designated as
“low” in other studies. However, because many studies have
grouped different types of pancreatic resections together
[10], and to be consistent with a large study which showed a
volume-outcome relationship for pancreatic head resections
[3], we chose to split them up in order to see whether there
was any specific predictive value for a given resection type.
Additionally, we still had a clear difference in the average
number of resections performed in high versus low volume
years.
In our analysis of other factors that may contribute to
morbidity and mortality, our results were mostly consistent
with previously reported data, with patients undergoing
pancreatic head resection experiencing more complications
than those undergoing non-head resection [20]. In our
series, 31.4% of patients had one or more surgical com-
plications following pancreatic head resection, consistent
with the reported overall morbidity of 30–55% [22]. In our
study, the incidence of pancreatic fistula after pancreatic
head resection was 10.5% and consistent with prior reports
[23, 24], while the incidence following other pancreatic
resections was 3.9%. Our findings suggest that the creation of
the pancreatic anastomosis carries a higher risk of pancreatic
leak than transection of the pancreas. Interestingly, others
have reported a higher incidence of pancreatic fistulas with
left-sided pancreatic resections [25].
For patients with malignant disease, the overall surgical
complication rate was 34.4% compared to 25.3% for patients
with benign disease. Although patients with malignant dis-
ease tended to have more complications, only the incidence
of gastroparesis came close to differing significantly. This is
fairly consistent with other studies which have shown no dif-
ferences in surgical complications between these two patient
groups [4]. The higher observed incidence of gastroparesis
may be due to the higher incidence of gastroparesis reported
with malignancy itself [26–29].
Our study has many important limitations. First, it was
retrospective. A prospective study would have allowed more
accurate assessment of postoperative complications, since we
had relied on physician diagnosis and notation of complica-
tions in the medical record. As such, definitions of particular
diagnoses were likely inconsistent across physicians and the
time course of the study. Additionally, review of inpatient
charts indicated in-hospital mortality, but we were not able
to accurately assess deaths that may have occurred after
discharge, limiting the inclusion of potential deaths due to
late complications. Moreover, although we included over 500
patients in this study, the study is still limited to a single
hospital’s experience.
Clearly, many studies have observed lower mortality
rates for pancreatic resections performed at high-volume
hospitals. Understanding the precise mechanism behind this
association may allow us to improve outcomes for patients
facing diseases that require pancreatic resection. The fact that
this relationship is not borne out at a single hospital that
had fluctuations in volume over time, that race has been
shown to affect outcome for some procedures irrespective
of hospital volume [17], that clinical studies are less likely
to find volume-outcome relationships than administrative
studies [13], and that patient characteristics at high and
low volume hospitals differ significantly [9, 12], all points
to a much more complex explanation than volume alone.
Of course, these data give no insight into how hospitals
acquire the ability to provide good outcomes after pancreatic
resections. Surgical volume may indeed play a role; however,
annual volume alone does not appear to be an adequate
predictor of postoperative mortality at our institution. Even
if the answer were simply volume, we saw that implementing
regionalization faces considerable obstacles [10, 12]. The
goal then is to determine how to improve outcomes for
patients who will continue to be treated at low-volume
hospitals. Our findings suggest that excellent outcomes for
pancreatic resections are possible despite changes in volume.
Further investigation is needed into what elements make that
possible.
5. CONCLUSIONS
Annual volume of pancreatic resections does not predict
postoperative mortality at a major academic medical center.
With the exception of a lower incidence of bile leaks fol-
lowing pancreatic head resections performed in high volume
years, there are no differences in postoperative complications
following pancreatic resections in high versus low volume
years. These findings contradict previously published studies
and suggest the need for further investigation into the
predictors of outcomes following pancreatic resections.
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